Belite Bio (BLTE) Prepaid Assets (2021 - 2025)

Belite Bio (BLTE) posted quarterly Prepaid Assets of $486000.0 for Q4 2025, up 17.39% year-over-year from $414000.0 in Q4 2024, and down 69.49% quarter-over-quarter from $1.6 million in Q3 2025.

Belite Bio (BLTE) Prepaid Assets (2021 - 2025) Analysis & Trends

Belite Bio's Prepaid Assets history runs 5 years deep, the most recent figure standing at $486000.0 for Q4 2025.

  • In Q4 2025, Prepaid Assets rose 17.39% year-over-year to $486000.0; the TTM figure through Dec 2025 stood at $486000.0 (up 17.39% YoY), while the FY2025 annual figure was $486000.0, up 17.39% from the prior year.
  • Prepaid Assets for Q4 2025 stood at $486000.0, down from $1.6 million in the prior quarter.
  • The five-year high for Prepaid Assets was $1.6 million in Q3 2025, with the low at $50000.0 in Q4 2021.
  • The 5-year median for Prepaid Assets is $601000.0 (2022), against an average of $701000.0.
  • The sharpest annual moves came in 2022 and 2024: Prepaid Assets surged 1332.0% in 2022, then slumped 56.28% in 2024.
  • Belite Bio's Prepaid Assets stood at $50000.0 in 2021, then soared by 1332.0% to $716000.0 in 2022, then soared by 32.26% to $947000.0 in 2023, then plunged by 56.28% to $414000.0 in 2024, then gained by 17.39% to $486000.0 in 2025.
  • Business Quant data shows BLTE's Prepaid Assets at $486000.0 in Q4 2025, $1.6 million in Q3 2025, and $414000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Belite Bio 6.40 Bn 6.40 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 486,000.00
Sep 30, 2025 1.59 Mn
Dec 31, 2024 414,000.00
Dec 31, 2023 947,000.00
Dec 31, 2022 716,000.00
Dec 31, 2021 50,000.00